{"schema_version":"secwatch.filing_event.v1","accession":"0000719135-23-000049","form_type":"8-K","ticker":"APYX","cik":"0000719135","company_name":"Apyx Medical Corp","filed_at":"2023-08-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.490329+00:00","generated_at":"2026-06-11T08:56:37.780348+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Apyx Medical annual meeting elects 8 directors, ratifies auditor, approves 2023 incentive plan","bullets":["All 8 director nominees elected, including Andrew Makrides (18.7M for, 224K against) and Charles Goodwin (19.0M for, 21K against).","Ratification of RSM US LLP as auditor: 24,542,917 for, 26,534 against, 53,343 abstentions.","Approval of 2023 Share Incentive Plan: 15,970,459 for, 1,405,162 against, 1,613,512 abstentions.","Meeting held August 10, 2023; all proposals passed as recommended by the Board."],"urls":{"canonical":"https://secwatch.observer/filing/0000719135-23-000049","json":"https://secwatch.observer/filing/0000719135-23-000049.json","markdown":"https://secwatch.observer/filing/0000719135-23-000049.md","text":"https://secwatch.observer/filing/0000719135-23-000049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/719135/000071913523000049/0000719135-23-000049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/719135/000071913523000049/apyx-20230810.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T08:56:37.780348+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0224674dc99182b016e905d4b3d991b6dacc07b0","claim":"Apyx Medical Corp shareholders approved Ratification of RSM US LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-08-10 meeting.","evidence_excerpt":"Proposal 2: The Company’s stockholders ratified the appointment of RSM US LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 by the following vote: Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstained 24,542,917 26,534 53,343","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/719135/000071913523000049/0000719135-23-000049-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-08-10"}],"fact_type":"shareholder_vote"},{"claim_id":"41955f5913242297a715f0a01e3a1c4bfde7562e","claim":"Apyx Medical Corp shareholders approved Election of eight directors at the 2023-08-10 meeting.","evidence_excerpt":"On August 10, 2023, the following proposals were submitted to the stockholders of Apyx Medical Corporation (the “Company”) at its annual meeting of stockholders: (1) the election of eight (8) directors; (2) the ratification of RSM US LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023; and (3) the approval of the Company’s 2023 Share Incentive Plan.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/719135/000071913523000049/0000719135-23-000049-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-08-10"}],"fact_type":"shareholder_vote"},{"claim_id":"5db550433456cca26066994562f4ccc0b2ea0720","claim":"Apyx Medical Corp shareholders approved Approval of the 2023 Share Incentive Plan at the 2023-08-10 meeting.","evidence_excerpt":"Proposal 3: The Company’s stockholders approved the Company’s 2023 Share Incentive Plan by the following vote: Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstained 15,970,459 1,405,162 1,613,512","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/719135/000071913523000049/0000719135-23-000049-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-08-10"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}